PNC Financial Services Group’s Caribou Biosciences CRBU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.78K Hold
4,420
﹤0.01% 4207
2026
Q1
$8.4K Sell
4,420
-2
-0% -$3 ﹤0.01% 4031
2025
Q4
$7.03K Sell
4,422
-6
-0.1% -$13 ﹤0.01% 4097
2025
Q3
$10.3K Hold
4,428
﹤0.01% 3918
2025
Q2
$5.58K Buy
4,428
+615
+16% +$605 ﹤0.01% 4089
2025
Q1
$3.48K Buy
3,813
+3,476
+1,031% +$4.52K ﹤0.01% 4178
2024
Q4
$536 Buy
337
+137
+69% +$275 ﹤0.01% 4516
2024
Q3
$392 Hold
200
﹤0.01% 4595
2024
Q2
$328 Sell
200
-110
-35% -$352 ﹤0.01% 4587
2024
Q1
$1.59K Hold
310
﹤0.01% 4260
2023
Q4
$1.78K Buy
310
+110
+55% +$544 ﹤0.01% 4218
2023
Q3
$956 Sell
200
-100
-33% -$620 ﹤0.01% 4383
2023
Q2
$1.27K Buy
300
+200
+200% +$899 ﹤0.01% 4467
2023
Q1
$531 Hold
100
﹤0.01% 4521
2022
Q4
$628 Hold
100
﹤0.01% 4482
2022
Q3
$1K Hold
100
﹤0.01% 4294
2022
Q2
$1K Hold
100
﹤0.01% 4319
2022
Q1
$1K Hold
100
﹤0.01% 4324
2021
Q4
$2K Hold
100
﹤0.01% 4135
2021
Q3
$2K Buy
+100
New +$2.44K ﹤0.01% 4089

Other funds holding CRBU

PNC Financial Services Group's CRBU Position: Q2 2026 in Review

PNC Financial Services Group held its Caribou Biosciences (CRBU) position steady in Q2 2026 at 4,420 shares worth $7.78K. The position accounts for ﹤0.01% of the portfolio, ranked #4207.

PNC Financial Services Group first reported a position in CRBU in Q3 2021 and has held it in 20 quarters since. The position peaked at $10.3K in Q3 2025. 45 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • PNC Financial Services Group held 4,420 shares of Caribou Biosciences worth $7.78K as of Q2 2026.
  • PNC Financial Services Group left its Caribou Biosciences share count unchanged in Q2 2026.
  • Caribou Biosciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4207 holding.
  • PNC Financial Services Group first reported a position in Caribou Biosciences in Q3 2021 and has held it in 20 quarters since.
  • PNC Financial Services Group's Caribou Biosciences position peaked at $10.3K in Q3 2025.
  • 45 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.